Comment on Post-marketing surveillance: a UK/European perspective.
Dornhorst
Anne
A
D003920:Diabetes Mellitus / Q000188:drug therapy*; D005060:Europe; D006801:Humans; D007328:Insulin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000069057:Insulin Detemir; D049528:Insulin, Long-Acting; D040541:Marketing; D015337:Multicenter Studies as Topic; D019370:Observation; D011358:Product Surveillance, Postmarketing; D011640:Public Policy; D016032:Randomized Controlled Trials as Topic; D006113:United Kingdom
D007328:Insulin; D049528:Insulin, Long-Acting; D000069057:Insulin Detemir